Cd14 — Cd14 Molecule is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| CD14 — CD14 Molecule | |
|---|---|
| Symbol | CD14 |
| Full Name | CD14 Molecule |
| Chromosome | 5q31.3 |
| NCBI Gene | 929 |
| Ensembl | ENSG00000144891 |
| OMIM | 158120 |
| UniProt | P08571 |
| Diseases | Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis |
| Expression | Monocytes, Macrophages, Neutrophils, Microglia |
CD14 is a gene located on chromosome 5q31.3 that encodes a co-receptor for Toll-like receptor 4 (TLR4), playing a critical role in innate immune responses to bacterial lipopolysaccharide (LPS) and other pathogen-associated molecular patterns (PAMPs). CD14 is expressed primarily on monocytes, macrophages, and neutrophils, as well as on microglia in the brain.
CD14 exists in both membrane-bound (mCD14) and soluble (sCD14) forms:
In the brain, CD14 on microglia mediates neuroinflammatory responses to various stimuli.
Alzheimer's Disease: CD14 is upregulated in AD brain and mediates microglial activation in response to amyloid-beta. CD14 polymorphisms may influence AD risk.
Parkinson's Disease: CD14 contributes to neuroinflammation in PD. LPS-induced microglial activation via CD14 may contribute to dopaminergic neuron loss.
Multiple Sclerosis): CD14 mediates inflammatory responses in MS lesions.
The study of Cd14 — Cd14 Molecule has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.